Topic 3 (midterm) Flashcards
2 general components of radiopharmaceutical
Radionuclide
Pharmaceutical
Are medicinal products designed for the use in the investigation or treatment of human diseases. Contain “radionuclide” as an integral part of the main ingredient. Are administered to a human subjects usually by intravenous injection.
Radiopharmaceuticals
The atoms involved and the only nuclei that undergo radioactive decay. Emits gamma ray as it decays. This is tagged to a radiopharmaceutical
Radionuclide
Any chemical substances intended for use in medical diagnosis, cure treatment or prevention of disease. Carries the radionuclide to the organ being examined. This is chosen in the basis of its preferential localization or participation in the physiological function of a given organ. Produces gamma-ray emission from within the organ is being studied.
Pharmaceuticals/tracer
The radionuclide decay should result in __ (100-300 keV is ideal for gamma cameras) and sufficient
abundance of emission of external detection.
gamma emissions of suitable energy
It should not contain particulate radiation (__), which increases patient’s radiation dose without adding diagnostic information.
beta emissions
are suitable for therapeutic radiopharmaceuticals.
Beta emissions
The __ should only be longer enough for the intended application, usually a few hours.
effective half-life
The specific activity should be __. (Tc-99m).
high
The pharmaceutical component should be free of any _ or _
toxicity or secondary effects.
Should be __ or easily compounded and should have a reasonable cost
readily available
The agent should __ localize according to the intended application.
rapidly and specifically
the radiopharmaceutical must achieve a satisfactory distribution in the body or trace a particular metabolic absorptive, excretory or other pathway.
Biological behaviour
A “__” or “__” produced with an area increased radioactivity.
Hot lesion or hot spot
__ is detected with decreased radioactivity
Cold lesion
Used to denote the organ or the volume which is desired to concentrate the radiopharmaceutical
Target
Areas of increased flow & metabolism e.g metastases and inflammatory lesion
Hot spot images
Areas of diminished flow or metabolism e.g cardia perfusion infarct
Cold spot images
The radionuclide must have suitable properties as regard radiation emitted energy and abundance of gamma rays and half-life
Radionuclide characteristics
This will depend on the mode of the production of the radionuclide, the nature of radiopharmaceutical and the cost
Availability
Most agents are injected intravenously and must therefore be of high __ quality
Pharmaceutical
Modes of administration of radiopharmaceutical
Injection-
Swallowing/ingesting
Inhalation
Instilling
Are products of microbacterial metabolism which produce fever when injected to human subjects. They are heat-stable and are not destroyed by normal methods of sterilisation.
Pyrogen
Involves cellular metabolic process that results in organ or tissue concentration above plasma levels.
Active Transport
Involves movement of substance from regions of higher concentration to a lower concentration.
Simple Diffusion
Particles larger than RBC’s are lodged at the first capillary bed it encounters.
Capillary blockade
Involves the recognition and removal of small foreign particles in the blood.
Phagocytosis
Process by the which the spleen recognition and removes the damaged RBC’s and cells nearing the end of heir life expectancy.
Cell Sequestration
Antibody complexion, It is a tumor localization
Antigen
most famous naturally occurring nuclide, was first used in treatment in 1903 (half-life of 1620 years)
Ra-226
other significant naturally occurring radionuclides
-0.012% of natural potassium is K-40, as the human body contains about 190g of potassium, this represents an activity of approximately 0.2uCi
K- 40 and C-14
is produced in the upper atmosphere due to the effect of cosmic radiation and becomes incorporated into plants and animals man.
C-14